FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:328-329 July 20, 2006 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Thyroid Cancer: A Comprehensive Guide to Clinical Management
Second edition. Edited by Leonard Wartofsky and Douglas Van Nostrand. 708 pp., illustrated. Totowa, N.J., Humana Press, 2006. $195. ISBN 1-58829-462-5.

Management of Thyroid Cancer and Related Nodular Disease
By I. Ross McDougall, with Gerald J. Berry. 397 pp., illustrated. London, Springer-Verlag, 2006. $189. ISBN 1-85233-965-9.

The prognosis for patients with differentiated thyroid cancer is generally very good, with a survival rate of more than 90 percent. However, approximately one third of patients with this diagnosis eventually have a recurrence of their disease. Because of the good prognosis, the indolent nature of this disease, and the behavior of the recurrences, treatment plans for thyroid cancer are derived almost entirely from large retrospective case series and consensus views of good practice. This reliance on the best available (but imperfect) evidence probably will not change, especially because a prospective trial . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.